Cargando…
153 Do Hydroxychloroquine, Disease-Modifying Antirheumatic Agents or Steroids, Serve to Prevent COVID-19 Infection?
Autores principales: | Keyes, D., Haidous, A., Lake, C., Stipek, K., McHugh, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598544/ http://dx.doi.org/10.1016/j.annemergmed.2020.09.165 |
Ejemplares similares
-
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
por: White, Nicholas J., et al.
Publicado: (2020) -
Implementing guidelines to prevent cancer associated thrombosis: how can we do better?
por: Ades, Steven, et al.
Publicado: (2023) -
Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate
por: Hobbs, FD Richard, et al.
Publicado: (2016) -
Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
por: Infante, Marco, et al.
Publicado: (2022) -
Chemically modified tetracyclines: Novel therapeutic agents in the management of chronic periodontitis
por: Agnihotri, Rupali, et al.
Publicado: (2012)